A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with ...

The safety findings were reported to be consistent with the known profiles of ficerafusp alfa and pembrolizumab, and post-treatment data from tumor biopsies indicated a promising downregulation of ...

PD-1 antibody was approved as first-line treatment for locally recurrent or metastatic squamous cell anal carcinoma.

The regulator’s priority review and sBLA approval of the antibody were supported by data from Phase III and Phase II trials.

The former president's office made the announcement on Sunday, about a week after a small prostate nodule was discovered ...

treatment options are limited for patients progressing after first-line therapy, reinforcing the need for new approaches. “Patients with metastatic esophageal squamous cell carcinoma continue to ...

Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the ...

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical ...

Jim Ross is sharing an update on his challenging health journey. The WWE Hall of Famer revealed that he has been diagnosed ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

"Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms," the statement reads, per CNN. "On Friday, he was diagnosed with ...